Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2023 Sep 1.

Published in final edited form as: J Surg Oncol. 2022 Apr 26;126(3):479–489. doi: 10.1002/jso.26895

Figure III | — Kaplan-Meier survival function by (A) NCCN guideline adherence with guideline-adherent primary treatment in blue and non-adherent primary treatment in red; (B) hospital guideline adherence quartile with lowest adherence quartile (Q1: 0–16%) in gray, quartile 2 (Q2: 16–25%) in red, quartile 3 (Q3: 25–35%) in blue, and highest adherence quartile (Q4: 35–76%) in orange; (C) hospital guideline adherence quartile with Q1 in gray and Q4 in orange among patients who received guideline-adherent treatment; and (D) hospital guideline adherence quartile with Q1 in gray and Q4 in orange among patients who did not receive guideline-adherent treatment.

Figure III | — Kaplan-Meier survival function by (A) NCCN guideline adherence with guideline-adherent primary treatment in blue and non-adherent primary treatment in red; (B) hospital guideline adherence quartile with lowest adherence quartile (Q1: 0–16%) in gray, quartile 2 (Q2: 16–25%) in red, quartile 3 (Q3: 25–35%) in blue, and highest adherence quartile (Q4: 35–76%) in orange; (C) hospital guideline adherence quartile with Q1 in gray and Q4 in orange among patients who received guideline-adherent treatment; and (D) hospital guideline adherence quartile with Q1 in gray and Q4 in orange among patients who did not receive guideline-adherent treatment.